| 1. | | Recruiting | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer |
| 2. | | Recruiting | Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer |
| 3. | | Recruiting | Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Conditions: stage III prostate cancer; stage II prostate cancer |
| 4. | | Recruiting | Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 5. | | Recruiting | Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia |
| 6. | | Recruiting | CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Condition: Endometrial Cancer |
| 7. | | Recruiting | Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Conditions: Quality of Life; stage IV colon cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV rectal cancer |
| 8. | | Recruiting | Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult diffuse small cleaved cell lymphoma; ... |
| 9. | | Recruiting | Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Conditions: stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer |
| 10. | | Recruiting | Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
Conditions: high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer |
| 11. | | Recruiting | Combination Chemotherapy in Treating Patients With Bladder Cancer
Conditions: stage I bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder |
| 12. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy With or Without Gefitinib in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
Conditions: Squamous Cell Lung Cancer; large cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ... |
| 13. | | Recruiting | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
| 14. | | Recruiting | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: adult Hodgkin's lymphoma |
| 15. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: stage I adult diffuse large cell lymphoma; contiguous stage II adult diffuse large cell lymphoma; ... |
| 16. | | Recruiting | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma |
| 17. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ... |
| 18. | | Recruiting | Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 19. | | Recruiting | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder |
| 20. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
Conditions: adult lymphocyte depletion Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; ... |
| 21. | | Recruiting | Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Conditions: anaplastic large cell lymphoma; recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; angioimmunoblastic T-cell lymphoma |
| 22. | | Recruiting | Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Conditions: stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; inflammatory breast cancer |
| 23. | | Recruiting | Exemestane Compared With Anastrozole, With or Without Celecoxib, in Treating Postmenopausal Women After Surgery for Primary Breast Cancer
Conditions: stage IIIA breast cancer; stage I breast cancer; stage II breast cancer |
| 24. | | Recruiting | Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
Condition: Breast Cancer |
| 25. | | Recruiting | Exemestane With or Without Celecoxib in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Condition: Breast Cancer |
| 26. | | Recruiting | Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed
Condition: Non-small cell lung cancer |
| 27. | | Recruiting | High-Dose Interferon alfa in Treating Patients With Stage II or Stage III Melanoma
Conditions: stage II melanoma; stage III melanoma |
| 28. | | Recruiting | Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage III prostate cancer; stage II prostate cancer |
| 29. | | Recruiting | Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
| 30. | | Recruiting | Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer |
| 31. | | Recruiting | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer |
| 32. | | Recruiting | Imatinib Mesylate (Gleevec; STI571) in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed by Surgery
Condition: gastrointestinal stromal tumor |
| 33. | | Recruiting | Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ... |
| 34. | | Not yet recruiting | Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Conditions: Quality of Life; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 35. | | Recruiting | Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
Conditions: stage I rectal cancer; stage II rectal cancer; stage III rectal cancer; adenocarcinoma of the rectum |
| 36. | | Recruiting | Radiation Therapy Following Surgery in Treating Women With Early-Stage Invasive Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer |
| 37. | | Recruiting | Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Endometrial Cancer
Conditions: stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma; ... |
| 38. | | Recruiting | Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Conditions: breast cancer in situ; intraductal breast carcinoma |
| 39. | | Recruiting | Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Conditions: Non-small cell lung cancer; Small Cell Lung Cancer |
| 40. | | Recruiting | Single-Fraction Radiation Therapy Compared With Multiple-Fraction Reirradiation Therapy in Treating Patients With Painful Bone Metastases
Conditions: bone metastases; Pain |
| 41. | | Recruiting | Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer
Conditions: recurrent prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate |
| 42. | | Recruiting | Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 43. | | Recruiting | Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 44. | | Recruiting | Trastuzumab in Treating Women With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 45. | | Recruiting | Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Conditions: untreated adult acute myeloid leukemia; untreated childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 46. | | Recruiting | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Conditions: acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ... |
| 47. | | Recruiting | ZD6474 in Treating Patients With Small Cell Lung Cancer
Conditions: extensive stage small cell lung cancer; limited stage small cell lung cancer |
